Bayer data at ESMO 2019 highlights innovation in cancer research - PRNewswire

Bayer data at ESMO 2019 highlights innovation in cancer research  PRNewswire

WHIPPANY, N.J., Sept. 20, 2019 /PRNewswire/ -- Bayer will present new data from the company's expanding oncology business at the European Society for ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more